 | • レポートコード：MRC2303I0248 • 出版社/出版日：Mordor Intelligence / 2023年1月23日 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥712,500 (USD4,750) | ▷ お問い合わせ |
| Corporate License | ￥1,312,500 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本調査レポートでは、世界の硝子体切除装置市場規模が、予測期間中に年平均7.4%で成長すると予測しています。本書では、硝子体切除装置の世界市場について調べ、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品別（硝子体手術装置、照明装置、輸液装置、器具、その他（可視化装置、光凝固装置、凍結療法装置））分析、用途別（糖尿病性網膜症、網膜剥離、黄斑円孔、硝子体出血、その他（飛蚊症、黄斑パッカー））分析、エンドユーザー別（病院、眼科診療所、外来手術センター）分析、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ、アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、その他）分析、競争状況、市場機会・将来の動向など、以下の構成でまとめております。また、Alcon、Bausch Health Companies Inc.、BVI、DORC Holding B.V.、Johnson & Johnson、Geuder AG、NIDEK CO.、Carl Zeiss Meditec AG、Hoya Surgical Optics、Topcon Corporationなどの企業情報が含まれています。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の硝子体切除装置市場規模：製品別 - 硝子体手術装置の市場規模 - 照明装置の市場規模 - 輸液装置の市場規模 - 器具の市場規模 - その他（可視化装置、光凝固装置、凍結療法装置）の市場規模 ・世界の硝子体切除装置市場規模：用途別 - 糖尿病性網膜症における市場規模 - 網膜剥離における市場規模 - 黄斑円孔における市場規模 - 硝子体出血における市場規模 - その他用途（飛蚊症、黄斑パッカー）における市場規模 ・世界の硝子体切除装置市場規模：エンドユーザー別 - 病院における市場規模 - 眼科診療所における市場規模 - 外来手術センターにおける市場規模 ・世界の硝子体切除装置市場規模：地域別 - 北米の硝子体切除装置市場規模 アメリカの硝子体切除装置市場規模 カナダの硝子体切除装置市場規模 メキシコの硝子体切除装置市場規模 … - ヨーロッパの硝子体切除装置市場規模 ドイツの硝子体切除装置市場規模 イギリスの硝子体切除装置市場規模 フランスの硝子体切除装置市場規模 … - アジア太平洋の硝子体切除装置市場規模 中国の硝子体切除装置市場規模 インドの硝子体切除装置市場規模 日本の硝子体切除装置市場規模 … - 中東・アフリカの硝子体切除装置市場規模 GCC諸国の硝子体切除装置市場規模 南アフリカの硝子体切除装置市場規模 … - 南米の硝子体切除装置市場規模 ブラジルの硝子体切除装置市場規模 アルゼンチンの硝子体切除装置市場規模 … - その他地域の硝子体切除装置市場規模 ・競争状況 ・市場機会・将来の動向 |
The Vitrectomy Devices Market is expected to register a CAGR of 7.4% over the forecast period.
The COVID-19 pandemic initially had a significant impact on the market for vitrectomy devices. As a safety response to the pandemic, hospitals worldwide reduced in-person checkups in outpatient departments to maximize the use of resources on the front to manage the pandemic. According to a cross-sectional study of 526,536 procedures across 17 institutions published in JAMA Ophthalmol 2021, there was a significant decrease in the use of lasers and cryotherapy, retinal detachment repairs, and other vitrectomies from mid-March 2020 to at least May 2020. Moreover, ophthalmology has been one of the most severely impacted specialties regarding patient numbers and surgeries, owing to a long waiting time and a fear among patients visiting medical facilities. However, the American Academy of Ophthalmology (AAO) indicated that urgent or emergent vitreoretinal surgical procedures should continue during the COVID-19 pandemic. Thus, the COVID-19 outbreak affected the market’s growth adversely in its preliminary phase; however, the market gained traction due to the normalcy in the number of vitrectomy surgeries globally.
Further, the increasing prevalence of diabetic retinopathy and retinal detachment and technological advances in vitrectomy procedures are among the major factors driving the growth of the market studied. According to the International Agency for the Prevention of Blindness (IAPB), approximately 93 million people globally have diabetic retinopathy. In addition, about 1 in 3 people with diabetes have some degree of diabetic retinopathy, and 1 in 10 are anticipated to develop a vision-threatening form of the disease. Such factors will likely boost the demand for vitrectomy devices, thereby contributing to the growth of the market studied.
According to the IDF, in 2021, approximately 537 million adults (20-79 years of age) were living with diabetes. In addition, it is anticipated that the total number of people living with diabetes will rise to 643 million by 2030 and 783 million by 2045. Furthermore, the Vision Loss Expert Group, a part of the IAPB Organization, estimated that in 2020, 1 million people were blind globally due to diabetic retinopathy, and over 3 million had moderate-to-severe vision impairment. Moreover, increasing screening for diabetic retinopathy and an increasing number of campaigns raising awareness of diabetic retinopathy is also driving the market growth. For instance, in November 2022, the All India Ophthalmological Society (AIOS) and Vitreo-Retinal Society of India (VRSI) commemorated World Diabetes Day by organizing a walking marathon to raise awareness for diabetic retinopathy. Thus, the increasing prevalence of diabetic retinopathy and retinal detachment is poised to accelerate the vitrectomy devices market globally and is expected to increase in the future, thereby driving the growth of the studied market over the forecast period.
Therefore, owing to the factors mentioned above, it is anticipated that the market studied will witness growth over the analysis period. However, patient discomfort and risks associated with the vitrectomy procedure are likely to impede the market’s growth.
Vitrectomy Devices Market Trends
Vitrectomy Systems Segment is Expected to Witness Growth Over the Forecast Period
Vitrectomy is a rapidly advancing field, with increasingly refined microsurgical instrumentation allowing for advanced techniques. In recent years, technological advances have further led to the miniaturization of the scleral incision to mitigate the trauma of the surgical procedure and increase the efficiency of the vitrectomy. Hence, owing to the advantages of advancing vitrectomy systems, the demand for these products is likely to increase among physicians, ultimately driving the market’s growth.
In recent years, several technological advancements in vitrectomy systems are further driving the market growth. For instance, high-speed vitrectomy systems with a cut rate of above 10,000 cuts/minute (CPM) have recently become popular. The higher cut rates lead to a decrease in retinal traction. Furthermore, continuous product launches by major players in the market are positively affecting the segment’s growth. For instance, in March 2022, DORC International launched EVA NEXUS, an integrated system with retina, cataract, and combined surgery capabilities. This product launch is anticipated to enhance its product portfolio significantly. Further, in July 2022, Bausch Health Companies, Inc. launched efficiency-enhancing upgrades for the Stellaris Elite vision enhancement system. The upgrades include increasing the maximum vacuum setting from 600 to 660 mmHg and enhancing the removable valve caps in the trocar/cannula system. Therefore, the vitrectomy systems segment is expected to witness significant growth over the forecast period due to the abovementioned factors.
North America is Expected to Dominate the Vitrectomy Devices Market
North America is expected to dominate the market owing to factors such as the easy availability of technologically advanced products, the growing prevalence of eye-related disorders, high awareness of diabetic retinopathy, and a significant uptake in medical screening in the region. In addition, the availability of skilled ophthalmologists and the increasing geriatric population in the United States are among the key factors contributing to the growth of the market studied in North America.
Key product launches and approvals, the high concentration of market players, and the manufacturer’s presence in the United States are some of the factors driving the growth of the vitrectomy devices market in the country. For instance, in April 2022, Carl Zeiss AG received FDA approval for the QUATERA 700 system. The ZEISS QUATERA 700 is designed to increase a surgeon’s workflow efficiency from the clinic to the operating room. These continuous product launches and approvals in the region are anticipated to drive market growth in the country.
Therefore, owing to the factors mentioned above, the growth of the studied market is anticipated in the North American region.
Vitrectomy Devices Market Competitor Analysis
The vitrectomy devices market is slightly consolidated due to the presence of limited companies operating globally and regionally. The competitive landscape includes an analysis of a few international as well as local companies that hold significant market shares, including Alcon, Bausch Health Companies Inc., BVI, DORC Holding B.V., Johnson & Johnson, Geuder AG, NIDEK CO., Carl Zeiss Meditec AG, Hoya Surgical Optics, and Topcon Corporation, among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Diabetic Retinopathy and Retinal Detachment
4.2.2 Technological Advances in Vitrectomy Procedures
4.3 Market Restraints
4.3.1 Patient Discomfort and Risks Associated with the Vitrectomy Procedure
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Product Type
5.1.1 Vitrectomy System
5.1.2 Illumination Devices
5.1.3 Infusion Devices
5.1.4 Instruments
5.1.5 Other Product Types (Visualization Devices, Photocoagulation Devices, Cryotherapy Devices)
5.2 By Application
5.2.1 Diabetic Retinopathy
5.2.2 Retinal Detachment
5.2.3 Macular Hole
5.2.4 Vitreous Hemorrhage
5.2.5 Other Applications (Vitreous floaters, Macular Pucker)
5.3 By End-Users
5.3.1 Hospitals
5.3.2 Ophthalmology Clinics
5.3.3 Ambulatory Surgical Centers
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Alcon
6.1.2 Bausch Health Companies Inc.
6.1.3 BVI
6.1.4 DORC Holding B.V.
6.1.5 Johnson & Johnson
6.1.6 Geuder AG
6.1.7 NIDEK CO.
6.1.8 Carl Zeiss Meditec AG
6.1.9 Hoya Surgical Optics
6.1.10 Topcon Corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
